WEIGAO GROUP: WEIGAO Orthopedics' net profit attributable to the parent company for the first three quarters was 207 million yuan, an increase of 26.24% year-on-year
WEIGAO GROUP released its third-quarter performance for 2024, with operating revenue of 1.106 billion yuan in the first three quarters, a year-on-year increase of 2.12%; net profit attributable to the parent company of 207 million yuan, a year-on-year increase of 26.24%; and basic earnings per share of 0.52 yuan. During the reporting period, the execution of volume-based procurement in orthopedics was stable, the market share of domestic brands increased, and the company enhanced its professional service level through sales model transformation and marketing structure optimization, driving revenue and sales growth
According to the Zhitong Finance APP, WEIGAO GROUP (01066) released the performance report for WEIGAO Orthopedics (688161.SH) for the third quarter of 2024. The company achieved an operating income of 1.106 billion yuan in the first three quarters, an increase of 2.12% year-on-year; the net profit attributable to shareholders of the listed company was 207 million yuan, an increase of 26.24% year-on-year; the basic earnings per share were 0.52 yuan.
The announcement stated that during the reporting period, the overall execution of orthopedic bulk procurement was stable, and the market share of domestic leading brands continued to rise. The company continues to transform its sales model, dividing its business units based on professional departments as the core dimension, promoting the optimization and upgrading of the marketing structure, achieving production line focus, and enhancing the professionalism and flexibility of the sales team, significantly improving the level of professional services to clinical settings, leading to continuous growth in production line revenue and sales volume
